Family Participation in CICU Rounds: RCT
FAM-CICU
Family Participation in Cardiac Intensive Care Unit Rounds: A Randomized Controlled Trial (The FAM-CICU Study)
1 other identifier
interventional
220
1 country
1
Brief Summary
This is a single-center, unblinded, pragmatic randomized controlled trial comparing family participation in cardiac ICU team rounds with usual care. We will recruit 112 family members. The primary outcome will be family member care satisfaction. Secondary outcomes will include family mental health and care engagement. The beliefs, attitudes, and knowledge of healthcare providers, including medical trainees, about family participation in rounds will be evaluated prior to and following the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 30, 2022
CompletedFirst Submitted
Initial submission to the registry
August 24, 2022
CompletedFirst Posted
Study publicly available on registry
September 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedSeptember 6, 2022
August 1, 2022
1.6 years
August 24, 2022
August 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Family Care Satisfaction as Measured by the FS-ICU Survey.
A mean improvement change in Family Satisfaction in the ICU (FS-ICU 24R) survey score in family members participating in rounds (intervention). The survey assesses family satisfaction with care in the ICU setting and is given at the end of the patient's stay in the Cardiac Intensive Care Unit. Survey scores are reported with a range of 0-100, where higher scores indicate increased satisfaction with care.
Within 2 weeks of cardiac ICU discharge
Secondary Outcomes (3)
Family Engagement in Care as Measured by the FAMily Engagement (FAME) Survey
Within 2 weeks of cardiac ICU discharge
Family Mental Health as Measured by the Hospital Anxiety and Depression Scale (HADS) Survey
Within 2 weeks of cardiac ICU discharge
Change in Attitudes and Knowledge of Healthcare Providers as measured by the QFIFE survey
Through study completion, up to 4 weeks
Study Arms (2)
Intervention
EXPERIMENTALThe intervention consists of family participation in morning interdisciplinary team rounds in the cardiac ICU. Family participation will consist of orientation, engagement, summary, questions, and communication follow-up by the care team.
Usual care
NO INTERVENTIONUsual care consists of interdisciplinary team rounds that occur outside the patient's room each morning without a family member present.
Interventions
When the team arrives at the participating family member's room, the family member will be invited by a member of the healthcare team to come out of the room. The rounding team and structure will be the same as the usual care group with the following exceptions: (1) the family member will be invited to participate in the rounds outside their relative's room; (2) the family member will be provided with an orientation to the medical team members; (3) the family member will be allowed to engage and participate throughout the rounds; (4) at the end of the rounds, the team will summarize the patient's daily care plan; (5) the family member will be prompted to ask questions.
Eligibility Criteria
You may qualify if:
- expected patient length of stay \>48 hours
- family member, as designated by the patient or surrogate decision maker
- able to participate in English or French
- willingness to participate in morning rounds
You may not qualify if:
- another family member has already participated in the study
- inability to provide informed consent in English or French
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
Related Publications (2)
Abdallah JP, Morel SBA, Soboleva N, Quan J, Price C, Goldfarb M. A Digital Tool to Improve Family Engagement in Acute Care: The NGAGE Randomized Pilot Feasibility Trial. CJC Open. 2025 Mar 11;7(6):743-749. doi: 10.1016/j.cjco.2025.03.007. eCollection 2025 Jun.
PMID: 40586017DERIVEDDebay V, Hallot S, Calderone A, Goldfarb M. Family Participation in Cardiovascular Intensive Care Unit Rounds: A Pilot Randomized Controlled Trial. CJC Open. 2023 May 16;5(8):619-625. doi: 10.1016/j.cjco.2023.05.002. eCollection 2023 Aug.
PMID: 37720185DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael J Goldfarb, MD,MSc
Jewish General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Health care providers will be blinded to participants who are randomized to usual care. The investigator and outcomes assessor will be blinded to treatment assignment.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2022
First Posted
September 6, 2022
Study Start
May 30, 2022
Primary Completion
December 30, 2023
Study Completion
December 30, 2023
Last Updated
September 6, 2022
Record last verified: 2022-08